Noventra Pharma | Tesamorelin 10mg | Compound Peptide Pen
Advanced Growth Hormone Releasing Hormone (GHRH) Research Compound
Noventra Pharma Tesamorelin is an investigational peptide research compound classified as a growth hormone releasing hormone (GHRH) analogue, widely studied in laboratory settings for its role in pituitary signalling pathways and growth hormone regulation mechanisms.
Tesamorelin is referenced in scientific research exploring endocrine signalling, growth hormone secretion dynamics, and lipid metabolism regulation within controlled experimental environments.
Developed as a 10mg compound peptide pen, this formulation is designed for laboratory preparation and controlled research applications where hormonal signalling and endocrine pathway analysis are of scientific interest.
Noventra Pharma Tesamorelin 10mg Compound Peptide Pen
• GHRH analogue research compound studied in endocrine pathway models
• Investigated in growth hormone signalling and secretion research
• Of interest in lipid metabolism and metabolic regulation studies
• Explored in pituitary function and hormonal feedback mechanisms
• 10mg pen format designed for laboratory preparation use
• High-purity investigational formulation from Noventra Pharma
• Manufactured for stability, consistency, and research reliability
• Strictly intended for laboratory research use only
⚖️ DISCLAIMER
This product is intended strictly for laboratory research purposes only. It is not a medicine and has not been evaluated or approved by the South African Health Products Regulatory Authority (SAHPHRA) for human or animal use.
This product is supplied strictly for laboratory research purposes only and is not intended for human consumption.
Products sold on this website are not intended to diagnose, treat, cure, or prevent any disease.
